Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Intangibles: 2019-2024

Historic Intangibles for Revolution Medicines (RVMD) over the last 6 years, with Dec 2024 value amounting to $63.3 million.

  • Revolution Medicines' Intangibles changed negligibly% to $63.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $63.3 million for FY2024, which is negligibly% changed negligibly from last year.
  • Revolution Medicines' Intangibles amounted to $63.3 million in FY2024, which was down 0.00% from $63.3 million recorded in FY2023.
  • Revolution Medicines' Intangibles' 5-year high stood at $63.3 million during FY2020, with a 5-year trough of $63.3 million in FY2020.
  • Moreover, its 3-year median value for Intangibles was $63.3 million (2024), whereas its average is $63.3 million.